HEADER TRANSFERASE/INHIBITOR 03-APR-20 6WFO TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH ACCOA AND AN TITLE 2 INHIBITOR (COMPOUND 4B) IDENTIFIED USING DNA ENCODED LIBRARY TITLE 3 TECHNOLOGY COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5, COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50, COMPND 6 NATE CATALYTIC SUBUNIT, NAA50; COMPND 7 EC: 2.3.1.258,2.3.1.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, DNA ENCODED LIBRARY, KEYWDS 2 ACCOA, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART REVDAT 2 06-MAR-24 6WFO 1 REMARK REVDAT 1 01-JUL-20 6WFO 0 JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU, JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY, JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO, JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON, JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM, JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50 JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY. JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 32550998 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 62.0 REMARK 3 NUMBER OF REFLECTIONS : 33141 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 1602 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.99 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 623 REMARK 3 BIN R VALUE (WORKING SET) : 0.1834 REMARK 3 BIN FREE R VALUE : 0.2847 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 40 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3698 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 270 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.53280 REMARK 3 B22 (A**2) : 1.12890 REMARK 3 B33 (A**2) : -0.59600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.11260 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.205 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.176 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.215 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.181 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4127 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5662 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1467 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 754 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4122 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 508 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4560 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.24 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.56 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WFO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248132. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.77 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33141 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 64.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.59700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NAA50 APO PROTEIN (13.0 MG/ML) WAS REMARK 280 INCUBATED WITH 4B AND ACCOA IN A 1:3:3 MOLAR RATIO ON ICE FOR 60 REMARK 280 MIN. RESERVOIR SOLUTION OF 0.1 M BIS_TRIS, PH 5.77 AND 24% W/V REMARK 280 PEG 3350 WAS MIXED 0.2UL:0.2UL WITH NAA50:4B:ACCOA COMPLEX, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 51.31500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 LYS A 155 REMARK 465 VAL A 156 REMARK 465 PRO A 157 REMARK 465 SER A 158 REMARK 465 GLY A 159 REMARK 465 GLN A 160 REMARK 465 ASN A 161 REMARK 465 ALA A 162 REMARK 465 ASP A 163 REMARK 465 VAL A 164 REMARK 465 GLN A 165 REMARK 465 LYS A 166 REMARK 465 THR A 167 REMARK 465 ASP A 168 REMARK 465 ASN A 169 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 LYS B 155 REMARK 465 VAL B 156 REMARK 465 PRO B 157 REMARK 465 SER B 158 REMARK 465 GLY B 159 REMARK 465 GLN B 160 REMARK 465 ASN B 161 REMARK 465 ALA B 162 REMARK 465 ASP B 163 REMARK 465 VAL B 164 REMARK 465 GLN B 165 REMARK 465 LYS B 166 REMARK 465 THR B 167 REMARK 465 ASP B 168 REMARK 465 ASN B 169 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 LYS C 2 REMARK 465 GLY C 3 REMARK 465 LYS C 155 REMARK 465 VAL C 156 REMARK 465 PRO C 157 REMARK 465 SER C 158 REMARK 465 GLY C 159 REMARK 465 GLN C 160 REMARK 465 ASN C 161 REMARK 465 ALA C 162 REMARK 465 ASP C 163 REMARK 465 VAL C 164 REMARK 465 GLN C 165 REMARK 465 LYS C 166 REMARK 465 THR C 167 REMARK 465 ASP C 168 REMARK 465 ASN C 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 140 CD CE NZ REMARK 470 ARG A 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 141 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 140 -67.49 -91.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 U3Y A 202 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U3Y A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACO B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U3Y B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACO C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U3Y C 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6WF3 RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WF5 RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WFG RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WFK RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WFN RELATED DB: PDB REMARK 900 SAME PUBLICATION DBREF 6WFO A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WFO B 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WFO C 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 SEQADV 6WFO GLY A -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFO SER A 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFO GLY B -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFO SER B 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFO GLY C -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFO SER C 0 UNP Q9GZZ1 EXPRESSION TAG SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 A 171 ASP ASN SEQRES 1 B 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 B 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 B 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 B 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 B 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 B 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 B 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 B 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 B 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 B 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 B 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 B 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 B 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 B 171 ASP ASN SEQRES 1 C 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 C 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 C 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 C 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 C 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 C 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 C 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 C 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 C 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 C 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 C 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 C 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 C 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 C 171 ASP ASN HET ACO A 201 51 HET U3Y A 202 62 HET ACO B 201 51 HET U3Y B 202 62 HET ACO C 201 51 HET U3Y C 202 62 HETNAM ACO ACETYL COENZYME *A HETNAM U3Y (4S)-1-METHYL-N-{(3S,5R)-5-[4-(METHYLCARBAMOYL)-1,3- HETNAM 2 U3Y THIAZOL-2-YL]-1-[4-(1H-TETRAZOL-5-YL)BENZENE-1- HETNAM 3 U3Y CARBONYL]PYRROLIDIN-3-YL}-2,6- HETNAM 4 U3Y DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXAMIDE FORMUL 4 ACO 3(C23 H38 N7 O17 P3 S) FORMUL 5 U3Y 3(C23 H24 N10 O5 S) FORMUL 10 HOH *82(H2 O) HELIX 1 AA1 ASN A 15 PHE A 27 1 13 HELIX 2 AA2 ASN A 32 LEU A 40 1 9 HELIX 3 AA3 GLU A 41 GLU A 44 5 4 HELIX 4 AA4 ALA A 81 ARG A 84 5 4 HELIX 5 AA5 GLY A 87 GLY A 104 1 18 HELIX 6 AA6 ASN A 117 PHE A 127 1 11 HELIX 7 AA7 ASN B 15 PHE B 27 1 13 HELIX 8 AA8 ASN B 32 LEU B 40 1 9 HELIX 9 AA9 GLU B 41 GLU B 44 5 4 HELIX 10 AB1 ALA B 81 ARG B 84 5 4 HELIX 11 AB2 GLY B 87 GLY B 104 1 18 HELIX 12 AB3 ASN B 117 PHE B 127 1 11 HELIX 13 AB4 ASN C 15 PHE C 27 1 13 HELIX 14 AB5 ASN C 32 LEU C 40 1 9 HELIX 15 AB6 GLU C 41 GLU C 44 5 4 HELIX 16 AB7 ALA C 81 ARG C 84 5 4 HELIX 17 AB8 GLY C 87 GLY C 104 1 18 HELIX 18 AB9 ASN C 117 PHE C 127 1 11 SHEET 1 AA1 7 ILE A 6 GLY A 9 0 SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O TYR A 50 N GLU A 7 SHEET 3 AA1 7 ILE A 54 SER A 66 -1 O GLY A 57 N ALA A 49 SHEET 4 AA1 7 GLN A 69 CYS A 79 -1 O ARG A 71 N ASP A 64 SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O ASN A 108 N LEU A 72 SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O HIS A 148 N VAL A 113 SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147 SHEET 1 AA2 7 ILE B 6 ASP B 10 0 SHEET 2 AA2 7 ALA B 46 PHE B 51 -1 O TYR B 50 N GLU B 7 SHEET 3 AA2 7 ILE B 54 SER B 66 -1 O GLY B 57 N ALA B 49 SHEET 4 AA2 7 GLN B 69 CYS B 79 -1 O ARG B 71 N ASP B 64 SHEET 5 AA2 7 ASN B 108 GLN B 114 1 O TYR B 110 N LEU B 72 SHEET 6 AA2 7 ALA B 147 ASN B 153 -1 O HIS B 148 N VAL B 113 SHEET 7 AA2 7 GLU B 130 LYS B 135 -1 N LYS B 135 O ALA B 147 SHEET 1 AA3 7 ILE C 6 ASP C 10 0 SHEET 2 AA3 7 ALA C 46 PHE C 51 -1 O TYR C 50 N GLU C 7 SHEET 3 AA3 7 ILE C 54 SER C 66 -1 O GLY C 57 N ALA C 49 SHEET 4 AA3 7 GLN C 69 CYS C 79 -1 O ARG C 71 N ASP C 64 SHEET 5 AA3 7 ASN C 108 GLN C 114 1 O TYR C 110 N ILE C 74 SHEET 6 AA3 7 ALA C 147 ASN C 153 -1 O HIS C 148 N VAL C 113 SHEET 7 AA3 7 GLU C 130 LYS C 135 -1 N GLU C 133 O VAL C 149 CISPEP 1 GLU A 143 PRO A 144 0 -5.83 CISPEP 2 GLU B 143 PRO B 144 0 -3.32 CISPEP 3 GLU C 143 PRO C 144 0 -1.81 SITE 1 AC1 26 ILE A 26 PHE A 27 ILE A 74 MET A 75 SITE 2 AC1 26 THR A 76 LEU A 77 GLY A 78 CYS A 79 SITE 3 AC1 26 ARG A 84 ARG A 85 LEU A 86 GLY A 87 SITE 4 AC1 26 ILE A 88 GLY A 89 THR A 90 HIS A 112 SITE 5 AC1 26 ASN A 117 SER A 119 ALA A 120 ASP A 122 SITE 6 AC1 26 PHE A 123 LYS A 126 U3Y A 202 HOH A 301 SITE 7 AC1 26 HOH A 305 HOH A 310 SITE 1 AC2 15 PHE A 27 VAL A 29 TYR A 31 TYR A 73 SITE 2 AC2 15 MET A 75 HIS A 112 VAL A 113 GLN A 114 SITE 3 AC2 15 TYR A 138 TYR A 139 LYS A 140 ARG A 141 SITE 4 AC2 15 ACO A 201 HOH A 313 HOH A 320 SITE 1 AC3 26 ILE B 26 PHE B 27 ILE B 74 MET B 75 SITE 2 AC3 26 THR B 76 LEU B 77 GLY B 78 CYS B 79 SITE 3 AC3 26 ARG B 84 ARG B 85 LEU B 86 GLY B 87 SITE 4 AC3 26 ILE B 88 GLY B 89 THR B 90 HIS B 112 SITE 5 AC3 26 ASN B 117 SER B 119 ASP B 122 PHE B 123 SITE 6 AC3 26 LYS B 126 U3Y B 202 HOH B 301 HOH B 303 SITE 7 AC3 26 HOH B 307 HOH B 332 SITE 1 AC4 16 PHE B 27 PRO B 28 VAL B 29 TYR B 31 SITE 2 AC4 16 ARG B 62 TYR B 73 MET B 75 HIS B 112 SITE 3 AC4 16 VAL B 113 GLN B 114 TYR B 138 TYR B 139 SITE 4 AC4 16 LYS B 140 ARG B 141 ACO B 201 HOH B 326 SITE 1 AC5 27 ILE C 26 PHE C 27 ILE C 74 THR C 76 SITE 2 AC5 27 LEU C 77 GLY C 78 CYS C 79 ARG C 84 SITE 3 AC5 27 ARG C 85 LEU C 86 GLY C 87 ILE C 88 SITE 4 AC5 27 GLY C 89 THR C 90 HIS C 112 ASN C 117 SITE 5 AC5 27 SER C 119 ASP C 122 PHE C 123 LYS C 126 SITE 6 AC5 27 U3Y C 202 HOH C 301 HOH C 303 HOH C 305 SITE 7 AC5 27 HOH C 307 HOH C 311 HOH C 316 SITE 1 AC6 17 PHE C 27 VAL C 29 SER C 30 TYR C 31 SITE 2 AC6 17 ARG C 62 ASP C 64 TYR C 73 MET C 75 SITE 3 AC6 17 HIS C 112 VAL C 113 GLN C 114 TYR C 138 SITE 4 AC6 17 TYR C 139 LYS C 140 ARG C 141 ACO C 201 SITE 5 AC6 17 HOH C 308 CRYST1 47.870 102.630 67.500 90.00 106.08 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020890 0.000000 0.006022 0.00000 SCALE2 0.000000 0.009744 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015418 0.00000